曲安奈德（TA）作为模型药物，壳聚糖与明胶作为载体，溶剂挥发法成膜。
Using triamcinolone acetonide(TA) as a model drug, the drug membranes with chitosan and gelatin as carriers are prepared through solvent volatilization.
在此基础上，采用乳化溶剂挥发法和液致相分离相结合制备了聚乳酸多孔微球。
Moreover, PLA porous microspheres were fabricated by solution induced phase separation based on emulsion-solvent evaporation.
用溶剂自然挥发法培养了五个单晶，并采用CCD 单晶衍射仪测定了它们的晶体结构。
Five crystal structures are determined by CCD diffractometer after the single crystals were grown by slow evaporation at room temperature.
以丙烯酸树脂RL 100为包衣材料，采用乳剂-溶剂挥发法，制备了以药物-树脂为丸芯的缓释微丸。
By in-liquid drying, sustained-release pellets were prepared taking Eurdragit RL100 as coating material and drug-resin complex as core.
以丙烯酸树脂RL 100为包衣材料，采用乳剂-溶剂挥发法，制备了以药物-树脂为丸芯的缓释微丸。
By in-liquid drying, sustained-release pellets were prepared taking Eurdragit RL100 as coating material and drug-resin complex as core.
应用推荐